🇺🇸 FDA
Patent

US 8840905

Use of neurotoxin therapy for treatment of urologic and related disorders

granted A61KA61K31/16A61K31/353

Quick answer

US patent 8840905 (Use of neurotoxin therapy for treatment of urologic and related disorders) held by The Regents of the University of Colorado expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado
Grant date
Tue Sep 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/16, A61K31/353, A61K38/4893, A61P